Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The investigators aim to evaluate the efficiency and toxicities of induction chemotherapy of
docetaxel, cisplatin and xeloda in nomogram-predicted high risk locoregionally advanced
nasopharyngeal carcinoma.